Business Wire: July 5, 2017 – CLEVELAND, OH, U.S.A. – Diasome Pharmaceuticals, Inc., an innovative life sciences technology company focused on the development of novel therapies for the treatment of diabetes and other metabolic conditions, announced the agreement today of new funding of up to $30…
